11 Jan 2019 Research

Myelofibrosis: Finding new ways to treat patients

Myelofibrosis is a fatal bone marrow cancer. The disease is caused by excessive secretion of factors by cancerous platelet-producing cells called megakaryocytes. These secretions cause the replacement of normal bone marrow tissue with fibrous scar tissue.

Dr Chen’s team can successfully recreate this pathological bone marrow environment in the laboratory, and their preliminary research data shows that reduced levels of a protein complex called FANCcore leads to more myelofibrosis.

Dr Chen’s team hypothesise that loss of the protein complex FANCcore increases the growth of myelfibrosis by altering megakaryocytes. Dr Chen uses both human tissue cultures and mouse models to examine the cellular and molecular changes to megakaryocytes following the absence of the FANCcore complex and to understand how these changes cause myelofibrosis.

The team hopes that by focusing on the role of FANCcore in megakaryocyte biology, they can reveal new ways to treat myelofibrosis.

Related posts

John Goldman Fellowships for 2023 now open

5 December 2022

John Goldman Fellowships for 2023 now open

Leukaemia UK is delighted to announce that we are funding more ground-breaking research in 2023, by continuing our investment in early career scientists and clinicians for our prestigious John Goldman…

TV baker Juliet Sear announced as Leukaemia UK Ambassador

6 March 2024

TV baker Juliet Sear announced as Leukaemia UK Ambassador

Leukaemia UK is excited to announce long-time supporter Juliet Sear as their latest celebrity Ambassador. Juliet, who has been an enthusiastic supporter of Leukaemia UK for several years now, wanted…

John Goldman Fellowships for 2022 open in December

16 November 2021

John Goldman Fellowships for 2022 open in December

Leukaemia UK is delighted to continue its investment and funding for early career scientists and clinicians in 2022.

“Henry’s death cannot have been for nothing” says bereaved Mum as charities fund new research into devastating infant leukaemia

31 August 2023

“Henry’s death cannot have been for nothing” says bereaved Mum as charities fund new research into devastating infant leukaemia

Callan Brett, a mother-of-two from Ipswich, has welcomed news of a pioneering new research project into infant leukaemia; having lost her youngest son to the rare form of blood cancer…